Skip to main content

Headlines

Nvidia Led the First Phase of Artificial Intelligence (AI), but These 2 Growth Stocks Will Lead the Next Phases, According to a Wall Street Team
posted:
by: Nasdaq AMZN Amazon
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #AMZN, #Amazon
Crinetics Pharma Stock Rises On Announcement Of Positive Data From Phase 3 Studies Of Paltusotine
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Innovent : Phase 2 Trial Of IBI302 In Neovascular Age-related Macular Degeneration Meets Main Goal
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Sanofi's Phase 2b Results Support Amlitelimab's Potential In Atopic Dermatitis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
ARS Pharma's Neffy Shows Rapid Symptom Control In Phase 2 Urticaria Clinical Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
GSK: Gepotidacin EAGLE-1 Phase III Trial In GC Reports Positive Headline Results
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Larimar Therapeutics Reports Positive Data From Nomlabofusp Phase 2 Study In FA Patients
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
CSL Reports Negative Outcome In Phase 3 Trial Of CSL112 In Heart Attack Treatment
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Oragenics Preparing For Phase II Trial In Treatment Of Concussion - Quick Facts
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Ethereum Surges 8%, Analysts Split Between Bullish 'Accelerated Phase' And Underperformance Against Bitcoin
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
Kura Gains 17% Over Positive Preliminary Clinical Data From Phase 1 Trial Of Ziftomenib
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Merck's Keytruda Reduces Risk Of Death By 38% In Adjuvant RCC Therapy In Phase 3 Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Altcoins Bleeding In Correction Phase: 'This Is Nothing More Than A Buy The Dip Opportunity,' Says Analyst
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk
Annovis Bio Says Phase III Study Data Release For Buntanetap In Parkinson's Disease Postponed
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
The Next Phase of DeFi Is Here
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk